124 related articles for article (PubMed ID: 29568359)
1. CD151 promotes cell metastasis via activating TGF-β1/Smad signaling in renal cell carcinoma.
Yu Y; Liang C; Wang S; Zhu J; Miao C; Hua Y; Bao M; Cao Q; Qin C; Shao P; Wang Z
Oncotarget; 2018 Mar; 9(17):13313-13323. PubMed ID: 29568359
[TBL] [Abstract][Full Text] [Related]
2. The metastasis suppressor CD82/KAI1 regulates cell migration and invasion via inhibiting TGF-β 1/Smad signaling in renal cell carcinoma.
Zhu J; Liang C; Hua Y; Miao C; Zhang J; Xu A; Zhao K; Liu S; Tian Y; Dong H; Zhang C; Li P; Su S; Qin C; Wang Z
Oncotarget; 2017 Aug; 8(31):51559-51568. PubMed ID: 28881668
[TBL] [Abstract][Full Text] [Related]
3. CD151 promotes breast cancer metastasis by activating TGF-β1/Smad signaling pathway.
Zhao SJ; Zhao HD; Li J; Zhang H; Gao DT; Wang Q
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7314-7322. PubMed ID: 30468476
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA BX357664 regulates cell proliferation and epithelial-to-mesenchymal transition via inhibition of TGF-β1/p38/HSP27 signaling in renal cell carcinoma.
Liu Y; Qian J; Li X; Chen W; Xu A; Zhao K; Hua Y; Huang Z; Zhang J; Liang C; Su S; Li P; Shao P; Li J; Qin C; Wang Z
Oncotarget; 2016 Dec; 7(49):81410-81422. PubMed ID: 27806310
[TBL] [Abstract][Full Text] [Related]
5. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma.
Dong L; Ge XY; Wang YX; Yang LQ; Li SL; Yu GY; Gao Y; Fu J
Oral Oncol; 2013 Nov; 49(11):1051-8. PubMed ID: 23962790
[TBL] [Abstract][Full Text] [Related]
7. Fibronectin Promotes Cell Growth and Migration in Human Renal Cell Carcinoma Cells.
Ou YC; Li JR; Wang JD; Chang CY; Wu CC; Chen WY; Kuan YH; Liao SL; Lu HC; Chen CJ
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31181623
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin-3-gallate attenuates transforming growth factor-β1 induced epithelial-mesenchymal transition via Nrf2 regulation in renal tubular epithelial cells.
Wang Y; Liu N; Su X; Zhou G; Sun G; Du F; Bian X; Wang B
Biomed Pharmacother; 2015 Mar; 70():260-7. PubMed ID: 25776510
[TBL] [Abstract][Full Text] [Related]
9. TGF-β1 mediates epithelial to mesenchymal transition via the TGF-β/Smad pathway in squamous cell carcinoma of the head and neck.
Yu C; Liu Y; Huang D; Dai Y; Cai G; Sun J; Xu T; Tian Y; Zhang X
Oncol Rep; 2011 Jun; 25(6):1581-7. PubMed ID: 21479366
[TBL] [Abstract][Full Text] [Related]
10. SMAD proteins directly suppress
Kaur G; Li CG; Chantry A; Stayner C; Horsfield J; Eccles MR
Oncotarget; 2018 Jun; 9(42):26852-26867. PubMed ID: 29928489
[TBL] [Abstract][Full Text] [Related]
11. Integrin signaling potentiates transforming growth factor-beta 1 (TGF-β1) dependent down-regulation of E-Cadherin expression - Important implications for epithelial to mesenchymal transition (EMT) in renal cell carcinoma.
Feldkoren B; Hutchinson R; Rapoport Y; Mahajan A; Margulis V
Exp Cell Res; 2017 Jun; 355(2):57-66. PubMed ID: 28363829
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis.
Kominsky SL; Doucet M; Brady K; Weber KL
J Bone Miner Res; 2007 Jan; 22(1):37-44. PubMed ID: 17032147
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of CAPN2 promotes cell metastasis and proliferation via AKT/mTOR signaling in renal cell carcinoma.
Miao C; Liang C; Tian Y; Xu A; Zhu J; Zhao K; Zhang J; Hua Y; Liu S; Dong H; Zhang C; Su S; Li P; Qin C; Wang Z
Oncotarget; 2017 Nov; 8(58):97811-97821. PubMed ID: 29228653
[TBL] [Abstract][Full Text] [Related]
15. Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
Kim YJ; Jeon Y; Kim T; Lim WC; Ham J; Park YN; Kim TJ; Ko H
Bioorg Med Chem Lett; 2017 Feb; 27(4):1081-1088. PubMed ID: 28110870
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-β1 signaling promotes epithelial-mesenchymal transition-like phenomena, cell motility, and cell invasion in synovial sarcoma cells.
Qi Y; Wang N; He Y; Zhang J; Zou H; Zhang W; Gu W; Huang Y; Lian X; Hu J; Zhao J; Cui X; Pang L; Li F
PLoS One; 2017; 12(8):e0182680. PubMed ID: 28829837
[TBL] [Abstract][Full Text] [Related]
17. Oxymatrine inhibits the migration of human colorectal carcinoma RKO cells via inhibition of PAI-1 and the TGF-β1/Smad signaling pathway.
Wang X; Liu C; Wang J; Fan Y; Wang Z; Wang Y
Oncol Rep; 2017 Feb; 37(2):747-753. PubMed ID: 27959430
[TBL] [Abstract][Full Text] [Related]
18. TGF-β1 inhibits the growth and metastasis of tongue squamous carcinoma cells through Smad4.
Wang X; Sun W; Zhang C; Ji G; Ge Y; Xu Y; Zhao Y
Gene; 2011 Oct; 485(2):160-6. PubMed ID: 21726607
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of epithelial-mesenchymal transition induced by TGF-β1 in neuroblastoma cells.
Shao JB; Gao ZM; Huang WY; Lu ZB
Int J Oncol; 2017 May; 50(5):1623-1633. PubMed ID: 28393230
[TBL] [Abstract][Full Text] [Related]
20. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
